HEPATITIS B TREATMENT VACCINE ON THE BASIS OF INACTIVATED, WHOLE RECOMBINANT HANSENULA POLYMORPHA CELLS EXPRESSING HBSAG

• 收藏
• 分享

专利权人:

Hemu Wang

发明人:

HEMU WANG,CHANGHUA WANG,JUN YANG

申请号：

US16088169

公开号：

US20190216921A1

申请日:

2017.03.16

申请国别(地区):

US

年份:

2019

代理人:

摘要：

A hepatitis B treatment vaccine on the basis of inactivated, fully recombinant Hansenula cells expressing HBsAg. The vaccine is the HBsAg expressed in recombinant Hansenula cells. 108 cells contain 6-10 μg HBsAg as an antigen； the vaccine contains a total of 16-21 HBsAg-specific CTL epitopes； the vaccine uses optimized inactivated, fully recombinant Hansenula cells as an adjuvant.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/